Chronic Kidney Disease (CKD) is estimated to affect around 10% of the global population, yet up to one-third of cases remain undiagnosed. Since genetic testing is increasingly
We’re proud to share that 4bases presented a scientific poster introducing InnoGraft — our innovative, minimally invasive solution for monitoring graft rejection in organ transplant patients. Congrats and thanks
4bases, a Swiss-based leader in innovative genetic diagnostic solutions for Next Generation Sequencing (NGS), proudly announces the launch of InnoGraft — a non-invasive, cost-effective, and highly sensitive
Organ transplantation, often the only remaining option for end-stage organ failure, is a highly complex field that presents numerous challenges. Among these, transplant rejection has long been
Powered by Lifency SA © 2025
